Infliximab in recalcitrant generalized pustular arthropatic psoriasis

European Journal of Dermatology

Volumn 18, Issue 1, 2008, Pages 71-73

  Vieira Serrão, Vasco ^a   Martins, Andréa ^a   Lopes, M João Paiva ^a  

^a HOSPITAL DOS CAPUCHOS   (Portugal)

Author keywords

Anti TNF alpha; Arthropatic; Biologics; Infliximab; Pustular psoriasis

Indexed keywords

CORTICOSTEROID; ETRETIN; INFLIXIMAB; METHOTREXATE;

ADULT; ARTICLE; CASE REPORT; DISEASE EXACERBATION; DRUG DOSE REDUCTION; FOLLOW UP; HISTORY; HOSPITAL PATIENT; HUMAN; MALE; PSORIATIC ARTHRITIS; QUALITY OF LIFE; SYMPTOM;

ANTIBODIES, MONOCLONAL; ARTHRITIS, PSORIATIC; HUMANS; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 38549131372     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: 10.1684/ejd.2008.0314     Document Type: Article

References (22)

1. Griffiths CE, Christophers E, Barker JN, Chalmers RJ, Chimenti S, Krueger GG, Leonardi C, Menter A, Ortonne JP, Fry L. A classification of psoriasis vulgaris according to phenotype. Br J Dermatol 2007; 156: 258-62.
2. Iizuka H, Takahashi H, Ishida-Yamamoto A. Pathophysiology of generalized pustular psoriasis. Arch Dermatol Res 2003; 295(Suppl 1): S55-S59.
3. Reich K, Nestle FO, Papp K, Ortonne JP, Evans R, Guzzo C, Li S, Dooley LT, Griffiths CE. EXPRESS study investigators. Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial. Lancet 2005; 366: 1367-74.
4. Nelson AA, Pearce DJ, Fleischer Jr. AB, Balkrishnan R, Feldman SR. Inpatient management of severe psoriasis. J Drugs Dermatol 2005; 4: 564-70.
5. Lewis TG, Tuchinda C, Lim HW, Wong HK. Life-threatening pustular and erythrodermic psoriasis responding to infliximab. J Drugs Dermatol 2006; 5: 546-8.
6. Elston GE, Charles-Holmes R, Carr RA. Precipitation of generalized pustular psoriasis by prednisolone. Clin Exp Dermatol 2006; 31: 133-4.
7. Telfer NR, Dawber RP. Generalized pustular psoriasis associated with withdrawal of topical clobetasol-17-propionate. J Am Acad Dermatol 1987; 17: 144-5.
8. Hong SB, Kim NI. Generalized pustular psoriasis following withdrawal of short-term cyclosporin therapy for psoriatic arthritis. J Eur Acad Dermatol Venereol 2005; 19: 522-3.
9. Cassandra M, Conte E, Cortez B. Childhood pustular psoriasis elicited by the streptococcal antigen: a case report and review of the literature. Pediatr Dermatol 2003; 20: 506-10.
10. Gaylor ML, Duvic M. Generalized pustular psoriasis following withdrawal of efalizumab. J Drugs Dermatol 2004; 3: 77-9.
11. Lee CS, Koo J. A review of acitretin, a systemic retinoid for the treatment of psoriasis. Expert Opin Pharmacother 2005; 6: 1725-34.
12. Lebwohl M, Menter A, Koo J, Feldman SR. Combination therapy to treat moderate to severe psoriasis. J Am Acad Dermatol 2004; 50: 416-30.
13. Rinaldi F, Provenzano G, Termini A, Spinello M, La Seta F. Long term infliximab treatment for severe psoriatic arthritis: evidence of sustained clinical and radiographic response. Ann Rheum Dis 2005; 64: 1375-6.
14. Katugampola RP, Lewis VJ, Finlay AY. The Dermatology Life Quality Index: assessing the efficacy of biological therapies for psoriasis. Br J Dermatol 2007; 156: 945-50.
15. Reich K, Nestle FO, Wu Y, Bala M, Eisenberg D, Guzzo C, Li S, Dooley LT, Griffiths CE. Infliximab treatment improves productivity among patients with moderate-to-severe psoriasis. Eur J Dermatol 2007; 17: 381-6.
16. Ozawa A, Ohkido M, Haruki Y, Kobayashi H, Ohkawara A, Ohno Y, Inaba Y, Ogawa H. Treatments of generalized pustular psoriasis: a multicenter study in Japan. J Dermatol 1999; 26: 141-9.
17. Augey F, Renaudier P, Nicolas JF. Generalized pustular psoriasis (Zumbusch): a French epidemiological survey. Eur J Dermatol 2006; 16: 669-73.
18. Roelofzen JH, Aben KK, Khawar AJ, Van de Kerkhof PC, Kiemeney LA, Van Der Valk PG. Treatment policy for psoriasis and eczema: a survey among dermatologists in the Netherlands and Belgian Flanders. Eur J Dermatol 2007; 17: 416-21.
19. Trent JT, Kerdel FA. Successful treatment of Von Zumbusch pustular psoriasis with infliximab. J Cutan Med Surg 2004; 8: 224-8.
20. Lisby S, Gniadecki R. Infliximab (Remicade) for acute, severe pustular and erythrodermic psoriasis. Acta Derm Venereol 2004; 84: 247-8.
21. Newland MR, Weinstein A, Kerdel F. Rapid response to infliximab in severe pustular psoriasis, von Zumbusch type. Int J Dermatol 2002; 41: 449-52.
22. Benoit S, Toksoy A, Brocker EB, Gillitzer R, Goebeler M. Treatment of recalcitrant pustular psoriasis with infliximab: effective reduction of chemokine expression. Br J Dermatol 2004; 150: 1009-12.